Deutsche Bank Starts ConforMIS (CFMS) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
UPDATE: Oppenheimer Starts ConforMIS (CFMS) at Outperform
July 27, 2015 7:40 AM EDT(Updated - July 27, 2015 9:12 AM EDT)
Oppenheimer initiated coverage on ConforMIS (NASDAQ: CFMS) with an Outperform rating and a price target of $26.
Analyst Steven Lichtman said, "CFMS's unique iFit technology provides custom implants designed to match the individual anatomy of a patient undergoing total... More
JPMorgan Starts ConforMIS (CFMS) at Overweight
July 27, 2015 7:39 AM EDTJPMorgan initiated coverage on ConforMIS (NASDAQ: CFMS) with an Overweight rating and a price target of $28.00.
For an analyst ratings summary and ratings history on ConforMIS click here. For more ratings news on ConforMIS click here.
Shares of ConforMIS closed at $22.12 yesterday.
... MoreWells Fargo Starts ConforMIS (CFMS) at Outperform
July 27, 2015 7:38 AM EDTWells Fargo initiated coverage on ConforMIS (NASDAQ: CFMS) with an Outperform rating.
For an analyst ratings summary and ratings history on ConforMIS click here. For more ratings news on ConforMIS click here.
Shares of ConforMIS closed at $22.12 yesterday.
... MoreUPDATE: Canaccord Genuity Starts ConforMIS (CFMS) at Buy
July 27, 2015 7:37 AM EDT(Updated - July 27, 2015 8:47 AM EDT)
Canaccord Genuity initiated coverage on ConforMIS (NASDAQ: CFMS) with a Buy rating and a price target of $27.00.
Analyst William J. Plovanic said, "We believe ConforMIS is a disruptive technology in the multi-billion dollar global orthopedic implant market.... More
